TransMedics Group, Inc. stock rating and score history
All changes in ratings, performance and outlook tracked over time.
TransMedics Group, Inc. stock price, chart patterns and momentum
Recent price movements, trend behaviour and momentum signals based on real-time market data.
What does TransMedics Group, Inc. do? Business model and key facts
Get the full picture of TransMedics Group, Inc.: what it builds, where it operates, and how it makes money.
Sector: Healthcare
Industry: Medical - Devices
Employees (FY): 898
TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body. The OCS suite encompasses specialized modules: OCS LUNG, which facilitates the preservation of standard criteria donor lungs for double-lung transplants; OCS Heart, designed for the extracorporeal perfusion and maintenance of donor hearts; and OCS Liver, dedicated to the preservation of donor livers. Founded in 1998, TransMedics is headquartered in Andover, Massachusetts.
Stocks related to TransMedics Group, Inc.
Selected based on industry alignment and relative market positioning.
Events and news impacting TransMedics Group, Inc. stock
Earnings, coporate decisions and industry developments that can affect the share price.
TransMedics Group, Inc. fundamentals and technical analysis
Financial fundamentals and technicals signals combined to access stability, momentum and market direction.
